Key Laboratory of Medical Molecular Virology (MOE/NHC), Research Unit of Cure of Chronic Hepatitis B Virus Infection (CAMS), Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, School of Basic Medical Sciences, Shanghai Medical College Fudan University, Shanghai, 200032, China.
State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Chem Biodivers. 2024 Aug;21(8):e202401146. doi: 10.1002/cbdv.202401146. Epub 2024 Jul 17.
Hepatitis B Virus (HBV) infection is a global public health challenge that seriously endangers human health. Soft coral, as a major source of terpenoids, contains many structurally novel and highly bioactive compounds. Sixteen cembranoids (1-16), including a new one named sinupedunol B (16), were isolated from the South China Sea Soft coral Sinularia pedunculata. The structure of the sinupedunol B (16) was determined through a combination of spectroscopic analysis and X-ray single-crystal diffraction. In this study, cembranoids isolated from Sinularia pedunculata were found of anti-HBV activity for the first time. Among them, flexilarin D (6) showed significant anti-HBV activity with an IC value of 5.57 μM without cytotoxicity. We then analyzed the structure-activity relationship (SAR). Furthermore, it is demonstrated that flexilarin D (6) can accelerate the formation of capsid, inhibit HBeAg, HBV core particle DNA, HBV total RNA and pregenomic RNA in a dose dependent manner. We also confirmed the anti-HBV activity of 6 in HepG2-NTCP infection system. Finally, we demonstrated the anti-HBV mechanism of these compounds by inhibiting the ENI/Xp enhancer/promoter.
乙型肝炎病毒(HBV)感染是一个全球性的公共卫生挑战,严重威胁着人类健康。软珊瑚作为萜类化合物的主要来源,含有许多结构新颖且具有高度生物活性的化合物。从南海软珊瑚 Sinularia pedunculata 中分离得到了 16 个海鞘素(1-16),包括一个新的化合物 sinupedunol B(16)。通过光谱分析和 X 射线单晶衍射的组合,确定了 sinupedunol B(16)的结构。本研究首次发现从 Sinularia pedunculata 中分离得到的海鞘素具有抗 HBV 活性。其中,flexilarin D(6)表现出显著的抗 HBV 活性,IC 值为 5.57μM,且无细胞毒性。然后,我们分析了结构-活性关系(SAR)。此外,研究表明 flexilarin D(6)可以剂量依赖的方式加速衣壳的形成,抑制 HBeAg、HBV 核心粒子 DNA、HBV 总 RNA 和前基因组 RNA。我们还在 HepG2-NTCP 感染系统中证实了 6 的抗 HBV 活性。最后,我们通过抑制 ENI/Xp 增强子/启动子来证明这些化合物的抗 HBV 机制。